We serve (2S)-2-amino-3-(1-tritylimidazol-4-yl)propanoic acid CAS:35146-32-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (2S)-2-amino-3-(1-tritylimidazol-4-yl)propanoic acid
CAS.NO:35146-32-8
Molecular Formula:C25H23N3O2
Molecular Weight:397.46900
Synonyms:
N(im)-trityl-L-histidine
L-His(trt)-OH
H-His(Trt)-OH
L-Histidine, 1-(triphenylmethyl)-
His(Trt)-OH
1-trityl-histidine
1-(TRIPHENYLMETHYL)-L-HISTIDINE
1-Trityl-L-histidine
N'-Trityl-L-histidine
2-amino-3-(N-tritylimidazolyl)propionic acid
Physical and Chemical Properties:
Density: 1.19 g / cm3
Boiling point: 584.8ºC at 760 mmHg
Flash point: 307.5ºC
Refractive index: 1.631
Specification:
Appearance:White crystal powder
Purity:≥99%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at -20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like (2S)-2-amino-3-(1-tritylimidazol-4-yl)propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-amino-3-(N-tritylimidazolyl)propionic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(TRIPHENYLMETHYL)-L-HISTIDINE Use and application,1-trityl-histidine technical grade,usp/ep/jp grade.
Related News: The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.N-Ethylethylenediamine manufacturer The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.VINYLMETHYLBIS(METHYLETHYLKETOXIMINO)SILANE supplier The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.2,4,6-Triisopropylbenzenesulfonyl Azide vendor A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.
